Long-Haul Drivers

Reviewed by SOMA HEALTH's Medical Research Team

Long-haul driving asks the body to do something it was not built for: hold one posture, in one seat, for hours at a stretch, while staying mentally switched on the entire time. The stiffness in your hips at a fuel stop and the flat, heavy feeling that settles in around hour six are both, at a cellular level, partly a story about mitochondria — the tiny structures inside your muscle and nerve cells that turn food and oxygen into usable energy. Urolithin A is a compound that has become a focus of research into mitochondrial quality. Here is what the science actually shows, what it does not, and where a driver's realistic expectations should sit.

Why hours behind the wheel wear on the body

Prolonged, near-motionless sitting is now well documented as an occupational strain for professional drivers. Reviews of occupational driving link long seated hours to musculoskeletal discomfort in the lower back, hips and shoulders, reduced circulation in the legs, and general fatigue that builds across a shift. None of that is mysterious: muscles that stay statically loaded without movement stiffen, blood pools, and the steady cognitive demand of the road is tiring in its own right. Good seating, scheduled movement breaks, hydration and sleep are the foundation, and nothing below replaces them.

Where urolithin A enters the picture is narrower and more specific. It does not change your posture or your schedule. What it targets is the cellular machinery that muscles rely on to keep producing energy and to stay in good working order over time.

What urolithin A is

Urolithin A is not something you eat directly in any meaningful amount. It is a postbiotic — a compound your gut bacteria make when you eat ellagitannins, the polyphenols found in pomegranates, walnuts and some berries. The catch is that only some people carry the right mix of gut microbes to convert those precursors into urolithin A, and even among converters the amount produced varies widely. That variability is a large part of why taking it as a defined dose has drawn scientific interest: it removes the guesswork of whether your own microbiome is making any.

Its most-studied mechanism is mitophagy — the housekeeping process by which cells identify worn-out or damaged mitochondria and recycle them, making room for healthier ones. Think of it as quality control for your cellular power plants. When mitophagy runs well, the mitochondrial pool stays cleaner and more efficient. If you want the deeper mechanism, our guide to mitophagy and our overview of mitochondrial health go further.

The human evidence, most established first

The strongest human data concern safety and muscle function, and it is worth being precise about what each trial measured.

Safety and mitochondrial signalling (human)

The first-in-human study, Andreux and colleagues in Nature Metabolism (2019), found urolithin A was safe and well tolerated at doses up to 1,000 mg per day, and that it produced a measurable shift in mitochondrial gene-expression signatures in the participants. That established a foundation: a defined oral dose reaches the body and engages mitochondria-related pathways without a safety signal at the doses tested.

Muscle endurance and strength (human)

Two randomized trials in adults are the most relevant to anyone whose work is physically taxing. Liu, D'Amico and colleagues (JAMA Network Open, 2022) studied older adults over roughly four months and reported improvements in measures of muscle endurance. Singh and colleagues (Cell Reports Medicine, 2022) studied middle-aged adults over four months, with 500 mg and 1,000 mg daily arms, and reported benefits for muscle strength and exercise performance. A 2024 randomized trial in resistance-trained men (Journal of the International Society of Sports Nutrition, 8 weeks) extended this work into a fitter population. These are structure/function findings about how muscles perform — not claims about treating any driving-related condition.

Newer human work: energy and inflammaging

More recent human research has looked beyond muscle. A 2025 randomized controlled trial published in Nature Aging (roughly 28 days) reported that urolithin A supported the mitochondrial health of immune cells in midlife adults, in the context of the low-grade inflammation that tends to accompany aging (sometimes called inflammaging). A separate 2025 trial in distance runners looked at endurance-focused outcomes. This is a young and still-growing body of work: a 2024 systematic review in Ageing Research Reviews concluded, fairly, that the human evidence for targeting aging with urolithin A is still emerging. We take that framing seriously.

Preclinical research: promising, but not human proof

Much of the original excitement came from laboratory work, which should be labeled clearly as preclinical. Ryu and colleagues (Nature Medicine, 2016) showed that urolithin A induced mitophagy and extended lifespan in the worm C. elegans, and improved muscle function in rodents. D'Amico and colleagues (Aging Cell, 2022) reported joint and cartilage benefits in osteoarthritis models — interesting given how much drivers complain of stiff, achy joints, but this was in animals, not people, and says nothing about treating joint disease. Early or preclinical research is also exploring possible roles in skin, gut, brain and heart tissue; those are hypotheses under investigation, not established human outcomes.

What this realistically means for a driver

Put honestly: urolithin A is not an alertness aid, and it is not a stimulant. It will not keep you awake, and it is no substitute for sleep, legal hours-of-service limits, or pulling over when you are tired. What the human evidence supports is narrower and slower-acting — support for the mitochondrial quality your muscles draw on, and, in trials, measurable gains in muscle strength and endurance over several months of daily use. For someone whose body is under the low-grade, repetitive load of long shifts, that is a reasonable thing to want to support, provided the expectations are set at the right level.

Because the muscle findings emerged over roughly four months of consistent intake, this is a daily habit, not a one-off. Our notes on how long urolithin A takes to work and its role in cellular energy add practical detail. Pair it with the basics that actually move the needle for drivers: get out of the cab and walk at stops, stretch the hip flexors and lower back, stay hydrated, and protect your sleep.

This is a wellness supplement, not a treatment. Back pain, sciatica, circulation problems, persistent fatigue or daytime sleepiness are medical matters — see your doctor rather than relying on any supplement, and talk to them before starting if you have a condition or take medication.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This guide is educational and is not a substitute for advice from a qualified healthcare provider.